Biomarkers are a bridge to the next frontier in immuno-oncology - STAT

Biomarkers are a bridge to the next frontier in immuno-oncology  STATNext-generation cancer therapies work, but not in everyone. Biomarkers can help identify good candidates and track whether a therapy is working.